Alcimed - Biotech Finances : Studies on the Orphan Drug Market
Three exclusive studies on the orphan drug market to boost your business development in Europe and in the USA.
Europe Study
Published 6th july 2009, 50 page publication in English available as a pdf document
€ 2 250 pre-order price(1)
€ 2 500 full price 
Europe Study + Subscription to Biotech Finances
Enjoy a year's subscription to Biotech Finances(2) with your payment.
€ 2 900 pre-order price
€ 3 150 full price 
US Study
Published 7th september 2009, 50 page publication in English available as a pdf document
€ 2 250 pre-order price(1)
€ 2 500 full price
USA Study + Subscription to Biotech Finances
Enjoy a year's subscription to Biotech Finances(2) with your payment.
€ 2 900 pre-order price 
€ 3 150 full price
Global Study(3)
Published 5th october 2009, 90 page publication in English available as pdf document
€ 3 600 pre-order price(1) 
€ 4 000 full price
Global comparison Study + Subscription to Biotech Finances
Enjoy a year's subscription to Biotech Finances(2) with your payment.
€ 4 250 pre-order price 
€ 4 650 full price
|
RELEVANT EXPERT CONTENT
In each study you will find:
- Pricing processes
- Reimbursement processes
- Price comparisons
- Comparison of reimbursements for orphan drugs
- Survey of incentives for orphan drugs development
The key issues that will allow you to better define access strategies to different markets and optimize your position within the orphan drug sector.
Author: Nadège Penhaleux
Distribution: Biotech Finances (contact Jacques-Bernard Taste, see details below)
Contact us !
For any questions or further information you can phone us on : +33.(0)980 085 145 or email on : jbtaste@biotech-finances.com
- The pre-order price will be available until the day before publication: 5th July 2009 for the Europe study, 6th September 2009 for the US study, and 4th October 2009 for the global study.
- Online subscription is for one year, in English or in French and with full access to the archives.
- The purchase of the global comparison study will allow you to obtain all three studies on the date of their publication.
|
Prices : Study only
| |
Pre-order prices (10% reduction) |
Publication dates |
Full price |
| Europe Study |
2 250 € |
6th July 2009 |
2 500 € |
| USA Study |
2 250 € |
7th September 2009 |
2 500 € |
Global Study (Europe and USA) |
3 600 € |
5th October 2009 |
4 000 € |
Prices : Study + Subscription to Biotech Finances :
| |
Pre-order prices (10% reduction) |
Publication dates |
Full price |
| Europe Study |
2 900 € |
6th July 2009 |
3 150 € |
| USA Study |
2 900 € |
7th September 2009 |
3 150 € |
Global Study (Europe and USA) |
4 250 € |
5th October 2009 |
4 650 € |
Payment methods :
|